Pharmascroll Research & Consulting and Market Publishers Ltd Sign Partnership Agreement
Hyderabad, India, February 22, 2018 --(PR.com)-- Market Publishers Ltd and Pharmascroll Research and Consulting signed a partnership agreement for quality market research promotion on Internet. MarketPublishers.com is now authorised to distribute and sell research reports elaborated by Pharmascroll.
Commenting on the agreement, Natalie Aster, Assistant Manager at Partners Department, said: “Pharmascroll is a renowned provider of diligent business advisory and market research into the pharmaceutical domain with a specific focus on chronic disease indications prevalent the world over. The company’s team is made up of numerous knowledgeable and devoted research analysts with deep experience in pharma, statistical and management field. The reports created by the analysts are aimed at providing answers to the key business questions of the pharma and medical insights teams and helping them make well informed business decisions. We are very happy to have Pharmascroll in our team and are confident that our cooperation will bring about positive outcomes for both parties and our multinational clients.”
Comprehensive market reports by Pharmascroll include but are not limited to:
PPMS- A Detailed Overview. The research study gives an all-round, granular overview and evaluation of primary progressive multiple sclerosis worldwide. It casts light on the disease indication’s epidemiology in the leading geographical regions, offers information on the medications prescribed and set to be prescribed for the indication. The study presents an all-encompassing assessment of the market size by drugs and country-wise in patient numbers and value sales alongside detailed forecasts.
Migraine- A Detailed Overview. The research study gives an all-round, granular overview and evaluation of Migraine worldwide. It casts light on the disease indication’s epidemiology split into Episodic and Chronic Migraine in the leading geographical regions, offers information on the medications prescribed and set to be prescribed for the indication. The study presents an all-encompassing assessment of the market size by drugs and country-wise in patient numbers and value sales alongside detailed forecasts.
SPMS- Disease Overview, Epidemiology and Drug Overview. The report provides a definition of the multiple sclerosis and reviews the various disease types. It then defines secondary progressive multiple sclerosis, uncovers the causes of the disease. The study profiles SPMS patients and reveals the symptoms, provides information on disease diagnosis, progression and impact on QoL; review SPMS epidemiology in leading markets. The report canvasses the factors influencing physicians’ decision concerning prescription, etc.
About Pharmascroll:
Pharmascroll is a diligent business consulting and market research firm focused solely towards pharmaceutical markets. The company consults and researches in majorly chronic disease indications prevalent across the globe. The research conducted by Pharmascroll analysts is targeted to provide analytical and logical answers to the key business questions of the pharmaceutical and medical insights teams and to make better informed business decisions with the detailed relevant information available.
Commenting on the agreement, Natalie Aster, Assistant Manager at Partners Department, said: “Pharmascroll is a renowned provider of diligent business advisory and market research into the pharmaceutical domain with a specific focus on chronic disease indications prevalent the world over. The company’s team is made up of numerous knowledgeable and devoted research analysts with deep experience in pharma, statistical and management field. The reports created by the analysts are aimed at providing answers to the key business questions of the pharma and medical insights teams and helping them make well informed business decisions. We are very happy to have Pharmascroll in our team and are confident that our cooperation will bring about positive outcomes for both parties and our multinational clients.”
Comprehensive market reports by Pharmascroll include but are not limited to:
PPMS- A Detailed Overview. The research study gives an all-round, granular overview and evaluation of primary progressive multiple sclerosis worldwide. It casts light on the disease indication’s epidemiology in the leading geographical regions, offers information on the medications prescribed and set to be prescribed for the indication. The study presents an all-encompassing assessment of the market size by drugs and country-wise in patient numbers and value sales alongside detailed forecasts.
Migraine- A Detailed Overview. The research study gives an all-round, granular overview and evaluation of Migraine worldwide. It casts light on the disease indication’s epidemiology split into Episodic and Chronic Migraine in the leading geographical regions, offers information on the medications prescribed and set to be prescribed for the indication. The study presents an all-encompassing assessment of the market size by drugs and country-wise in patient numbers and value sales alongside detailed forecasts.
SPMS- Disease Overview, Epidemiology and Drug Overview. The report provides a definition of the multiple sclerosis and reviews the various disease types. It then defines secondary progressive multiple sclerosis, uncovers the causes of the disease. The study profiles SPMS patients and reveals the symptoms, provides information on disease diagnosis, progression and impact on QoL; review SPMS epidemiology in leading markets. The report canvasses the factors influencing physicians’ decision concerning prescription, etc.
About Pharmascroll:
Pharmascroll is a diligent business consulting and market research firm focused solely towards pharmaceutical markets. The company consults and researches in majorly chronic disease indications prevalent across the globe. The research conducted by Pharmascroll analysts is targeted to provide analytical and logical answers to the key business questions of the pharmaceutical and medical insights teams and to make better informed business decisions with the detailed relevant information available.
Contact
Pharmascroll Research and Consulting Private Limited
Bhawna Gupta
+919776868067
www.pharmascroll.com
Bhawna Gupta
+919776868067
www.pharmascroll.com
Contact
Categories